PPCB Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 geg. 2024 @ 22:58):

Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia...

Stats
Dzisiejszy wolumen	9.57M
Średni wolumen	9.64M
Kapitalizacja rynkowa	184 777
EPS	$-0.0449 ( 2023-11-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-07-05	Zelinger Josef	Buy	15 000 000	Common Stock Purchase Warrant
2021-08-17	Kenyon Julian Norman	Buy	3 420 000	Common stock, par value $0.001
2021-08-17	Nathanielsz James Andrew	Buy	5 928 000	Common stock, par value $0.001
2021-08-17	Nathanielsz James Andrew	Buy	2 800 000	Common stock, par value $0.001
2021-08-17	Zelinger Josef	Sell	0	Common stock, par value $0.001

INSIDER POWER
100.00
Last 22 transactions
Buy: 280 061 820 \| Sell: 580 500

Propanc Biopharma, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Propanc Biopharma, Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-28 841.00 (0.00 %)
EPS:	$-1.530

FY	2023
Przychody:	$0
Zysk brutto:	$-28 841.00 (0.00 %)
EPS:	$-1.530

FY	2022
Przychody:	$0
Zysk brutto:	$-28 366.00 (0.00 %)
EPS:	$-1.530

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.800

Financial Reports:

No articles found.

Propanc Biopharma, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Propanc Biopharma, Inc.

Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.